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Most doctors can identify key papers that have influenced their
approach to the management of a particular clinical problem,
although sometimes the gestation period of this effect can be
very prolonged. In this short review I discuss the effects of a
seminal paper by Sheila Mackenzie from the early 1990s on
my current approach to the diagnosis and management of
chronic cough in children.
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T
he diagnosis of asthma has been influenced by
the vagaries of fashion. In the early 1990s,
Speight et al1 raised concern that asthma in
children was being underdiagnosed and under-
treated. Since then, the willingness of doctors to
make this diagnosis has increased considerably
and the pendulum has swung towards overdiag-
nosis and overtreatment. Although many factors
have undoubtedly contributed to this phenom-
enon, the increased availability of effective drugs
for asthma and the enthusiasm of the pharma-
ceutical industry to sell them must have played a
considerable part. Another factor has been poor
education, which has resulted in a tendency to
label any chronic respiratory symptoms in children
as being asthmatic in nature, unless proved
otherwise. The lack of accepted methods for
diagnosing asthma in young children and mis-
understandings between parents, patients and
doctors as to the meaning of terms such as wheeze
and ‘‘chest tightness’’ have added to the confusion.
One controversial issue has been the use of the
diagnostic label ‘‘cough variant asthma’’. The
nature, incidence and even existence of this entity
have been much debated since it was first
described by McFadden in adults in 19752 and in
children by Cloutier and Loughlin in 1981.3 These
studies claimed benefit from the use of isoprena-
line and theophyllines respectively. This diagnosis
was used increasingly throughout the 1980s and
into the 1990s, and it became accepted practice for
isolated persistent cough to be treated with a
combination of inhaled b agonists and corticoster-
oids. More worrying was the tendency of paedia-
tricians (myself included) to consider the apparent
lack of efficacy of inhaled corticosteroids in a
patient to be a problem of inadequate dosage
rather than diagnostic failure. This often resulted
in increasingly higher doses being used, usually in
retrospect, with no benefit and occasionally with a
detrimental outcome.4
McKenzie5 was one of the first to question this
practice and the very existence of the syndrome. She
pointed out that epidemiological studies supported
the observation that cough is a poor marker for
wheeze and atopic status, and the weak relation-
ships between cough, lung function changes and
increased bronchial responsiveness typical of
asthma. Furthermore, she pointed out the lack of
evidence of efficacy of b agonists and the absence of
any studies at that time on the use of inhaled
corticosteroids. She sensibly suggested that drugs
such as inhaled corticosteroids should not be used
until evidence of airway lability had been shown.
McKenzie’s paper came as a shock to me, and I
remember feeling threatened and somewhat
offended that my management of such a common
paediatric respiratory problem was being ques-
tioned. I was reassured when numerous eminent
paediatricians were moved to express similar senti-
ments in response to the original article,6–8 indicat-
ing that I was not alone. The article did, however,
have the intended effect, and McKenzie’s views
have now been largely vindicated. Recent Cochrane
reviews have found very little evidence to suggest
any benefit from either inhaled corticosteroids9 or b2
agonists in children with isolated cough.10
This paper made me think and question the
veracity of my own diagnoses. The difficulty was in
how to fill the diagnostic vacuum. The differential
diagnosis of chronic cough in children is long.
Recurrent viral respiratory tract infection is often
cited as the most common cause, but many children
visiting my clinic had symptoms in the absence of
any obvious viral precipitant. Fortunately, two new
tools which would have a profound effect on our
diagnostic abilities were emerging at this time—
namely, flexible fibreoptic bronchoscopy and high-
resolution computerised tomography (HRCT).
Bronchoscopy began to show many structural
abnormalities including tracheomalacia, broncho-
malacia and tracheal bronchi, which were often
unsuspected clinically. It could also confirm bacter-
ial infection and, if lavage was carried out via a
laryngeal mask airway, could differentiate between
upper airway colonisation and true infection of the
lower respiratory tract. HRCT also began to show
many abnormalities, even in children with a normal
plain chest radiograph. These included bronchiecta-
sis, which has now been shown to be a relatively
common problem,11 and evidence of small airway
disease, which may suggest obliterative bronchioli-
tis. Although these two tools have dramatically
improved our diagnostic abilities, they have mainly
served to refute the diagnosis of asthma, and
confirmation of a positive diagnosis still requires a
complex amalgamation of history, clinical features,
special investigations and assessment of the
response to treatment. We still require a single
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simple and reliable instrument to confirm a positive diagnosis of
asthma in children, and much effort has been expended towards
this. The latest candidate is measurement of nitric oxide in
exhaled breath (FeNO), with recent claims that changes in
treatment of children with known asthma can be titrated
according to changing levels.12 It remains to be seen whether
this tool will prove to be sufficiently sensitive, specific and robust
for routine clinical use.
Competing interests: None declared.
REFERENCES
1 Speight AN, Lee DA, Hey EN. Underdiagnosis and undertreatment of asthma in
childhood. BMJ 1983;286:1253–6.
2 McFadden ER. Exertional dyspnea and cough as preludes to acute attacks of
bronchial asthma. N Engl J Med 1975;292:555–9.
3 Cloutier MM, Loughlin EM. Chronic cough in children: a manifestation of airway
hyperactivity. Pediatrics 1981;67:6–12.
4 Todd G, Dunlop K, McNaboe J, et al. Growth and adrenal suppression in
asthmatic children treated with high-dose fluticasone propionate. Lancet
1996;348:27–9.
5 McKenzie S. Cough-but is it asthma? Arch Dis Child 1994;70:1–2.
6 Upton C. Cough-but is it asthma? Arch Dis Child 1994;70:450.
7 Lewis HM. Cough-but is it asthma? Arch Dis Child 1994;70:554.
8 Buchdahl RM, Munyard PF, Bush A. Cough-but is it asthma? Arch Dis Child
1994;71:283.
9 Tomerak AAT, McGlashan JJM, Lakhanpaul M, et al. Inhaled corticosteroids for
non-specific chronic cough in children. Cochrane Database Syst Rev 2005; Issue
4: CD004231. Doi: 10.1002/14651858.CD004231.pub2.
10 Tomerak AAT, Vyas H, Lakhanpaul M, et al. Inhaled beta2-agonists for non-
specific chronic cough in children. Cochrane Database Syst Rev 2005; Issue 3:
CD005373. Doi: 10.1002/14651858. CD005373.
11 Eastham KM, Fall AJ, Mitchell L, et al. The need to redefine non-cystic fibrosis
bronchiectasis in childhood. Thorax, 2004;59, 324–7.
12 Pijnenburg MW, Bakker EM, Hop-Wim C, et al. Titrating steroids on exhaled
nitric oxide in children with asthma: a randomized controlled trial. Am J Respir
Crit Care Med 2005;172:831–6.
How this paper changed my practice
What I learned from McKenzie’s review was not that cough
variant asthma does not exist, because the axiom remains that
it is unwise to use ‘‘never’’ in medicine and I do have a very
small number of patients who fit this label. Instead, it has made
the diagnosis of cough variant asthma one of exclusion. It has
led me to always seriously question the diagnosis when a
patient presents with isolated cough, especially in the absence
of other evidence of IgE-mediated disease. My threshold for
investigating such patients in detail is lower and has resulted in
an alternative diagnosis being reached with increased fre-
quency.
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